Testimonies from the Trenches: Innovations in Clinical Practice - 

Reconsidering the Role of Urine Drug Testing in OUD Treatment. 
This is a 15 minute didactic presentation. Experiences providing care during the COVID-19 pandemic has forced us to use measures other than Urine Drug Testing (UDT) to define successful treatment. The role of UDT warrants re-examination as we emerge from the pandemic. (This webinar is available for .25 CME)

This webinar is free to AOAAM members.
Non-members at $25. Consider membership!

1. Discuss the patient-centered harms and benefits of routine urine drug testing
2. Review on a high-level the literature on the practice of urine drug testing in addiction treatment
3. Consider alternative approaches to routine urine drug testing

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

1. Complete the required course materials.
2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

The activity is designed to encourage clinicians to consider modifying their clinical practice to improve the patient experience.

CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.